Trending News

AstraZeneca’s Tagrisso (osimertinib) has been accepted for use within NHS Scotland by the Scottish Medicines Consortium (SMC) as monotherapy for the first-line treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) mutations.1  Context  Lung cancer accounts for a quarter of all cancer deaths in Scotland, […]

DDW’s Megan Thomas spoke to key decision-makers from the drug discovery industry about their predictions on what 2022 holds for our sector, which can be downloaded and viewed for free from the DDW App for users of Apple or Android devices. “Carefully distinguishing true opportunities from passing fads will be key,” says Eric Wolford, Vice President of Global Medical […]

Sygnature Discovery, providers of drug discovery solutions, has appointed Dr Charles Woler as Chairman.  Woler’s career Dr Woler has held multiple key roles in the sector, including CEO at Roche France, Executive Chairman for Europe at SmithKline Beecham, and CEO at Cadus Pharmaceutical in the US.   Official comments  Woler said: “Sygnature has a reputation for delivering quality scientific work with a culture that […]

News round-up by DDW’s Megan Thomas for 10-14 January, 2022  Studies, approvals and research are at the heart of drug discovery, which has been exemplified in this week’s drug discovery news. Megan Thomas has rounded up her top five stories of the week.   Vaccine-like mRNA injection can be used to make CAR-T cells  A study from […]

With SLAS2022 confirmed to go ahead as both an in-person and hybrid event, the Innovation Award finalist presentations will take place on February 8, from 10AM- 5PM, and will be live-streamed to the online audience.   What is the SLAS Innovation Award? The SLAS Innovation Award consists of a $10,000 check presented to a winning presenting […]

The Winter issue of the Drug Discovery World Magazine is out now.   Featuring Specialty Spotlight on Ophthalmology, the magazine is available to download and read for free on the DDW App.   Key features of the Winter Issue include: How Quantum Computing Can Benefit Drug Discovery, Why The Emergence of Targeted Protein Degradation is So Exciting, plus exclusive interviews and articles on cancer research, synthetic biology and rare variant contribution to human disease.   Exclusive  DDW &  SLAS2022 supplement   This issue is also accompanied by an exclusive DDW & SLAS2022 supplement ahead of SLAS2022 in Boston, […]

Discover how process optimisation utilising automated synthetic biology solutions can remove the antibody sequence cloning bottleneck that divides high-content lead identification and downstream high throughput characterisation. If your work involves antibody discovery or process improvement in recombinant cloning don’t miss this whitepaper illustrating how Codex DNA’s synthetic biology solutions can accelerate antibody discovery workflows. In […]

Revelar Biotherapeutics and Twist Bioscience have announced that RBT-0813 binds to and neutralises the Omicron and Delta variants of SARS-CoV-2 in live virus studies.   What is RBT-0813?  RBT-0813 is a bispecific antibody discovered by Twist Biopharma and licensed to Revelar Biotherapeutics that targets epitopes on the SARS-CoV-2 spike protein. Revelar has continued to advance preclinical development of RBT-0813 to submit an Investigational […]

Are you interested in learning how single-cell RNA-seq can be applied to comprehensively characterise the gene therapy drug product? Or the importance of including proteogenomics in your single-cell analysis to characterise the complex tumour microenvironment?  On 3 February 2022, DDW will host a free event, supported by 10x Genomics. Reorganisation of the tumour microenvironment in response to KRASG12C […]

Marinomed Biotech, an Austrian biotech company, has announced results of the antiviral efficacy of iota-carrageenan (Carragelose) against the original SARS-CoV-2 strain and variants of concern (VOC), including the Delta variant. This has been published in the International Journal of Molecular Sciences.   Collaboration   The peer-reviewed study is the result of a collaboration between virologists at the Friedrich-Alexander-Universität […]